Cold Spring Harbor Laboratory (CSHL) is a private, non-profit biomedical research and educational institution and home to eight Nobel laureates, including Dr. James Watson, co-discoverer of DNA’s double helix. A world leader in cancer biology and genetics, CSHL is the only National Cancer Institute-designated Cancer Center on Long Island. Scientists at CSHL are currently conducting research aimed at developing new diagnostics and therapies for breast cancer. Research highlights include: -New class of potential drug targets -Clinical trials for HER-2 positive breast cancer -Developing “Liquid Biopsy ” technology to detect metastatic cells.

Cutting-Edge Research at CSHL

Camila dos Santos

Cancer cells, like stem cells, have the ability to multiply indefinitely. Now, new results show that blocking epigenetic factor BPTF may be key in turning that ability off. 

Nicholas Tonks

A scientific journey from discovery research to a clinical trial. Hear a veteran research scientist take us on a personal journey that begins with his discovery 25 years ago of a key enzyme involved in cell signaling.

David Spector

In preliminary animal tests, targeting a RNA known as "Malat1" strikes an impressive blow against metastatic breast cancer. Feat: Dr David L. Spector, Prof and Director of Research, CSHL 

Mikala Egeblad

Public lecture at Cold Spring Harbor Laboratory - March 11, 2014 Breast Cancer in living color: Inspiring new treatments